Retrospective analysis of the relationship between decline in FEV1 and abdominal circumference in male smokers: The Takahata study

International Journal of Medical Sciences

Volumn 10, Issue 1, 2012, Pages 1-7

  Sato, Masamichi ^a   Shibata, Yoko ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Aida, Yasuko ^a   Kishi, Hiroyuki ^a   Nunomiya, Keiko ^a   Nakano, Hiroshi ^a   Sato, Kento ^a   Watanabe, Tetsu ^a   Konta, Tsuneo ^a   Ueno, Yoshiyuki ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Abdominal circumference; Decline in FEV1; Health check; Smoker

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREDICTION; RETROSPECTIVE STUDY; SMOKING HABIT; SPIROMETRY; TREND STUDY; WAIST CIRCUMFERENCE;

ABDOMINAL CIRCUMFERENCE; DECLINE IN FEV1; HEALTH CHECK.; SMOKER;

ADULT; BODY MASS INDEX; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING; STATISTICS AS TOPIC; VITAL CAPACITY; WAIST CIRCUMFERENCE;

EID: 84871356622     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5003     Document Type: Article

References (37)

1. [Internet] Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/.
2. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009; 179: 35-40
3. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007; 12: 634-41
4. Maggi S, Siviero P, Gonnelli S, et al. Osteoporosis risk in patients with chronic obstructive pulmonary disease: The eolo study. J Clin Densitom. 2009; 12: 345-52
5. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32: 962-9
6. Takabatake N, Sata M, Inoue S, et al. A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 172: 1097-104
7. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002; 121: 127S-30S.
8. Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009; 9: 375-83
9. Clini E, Crisafulli E, Radaeli A, et al. COPD and the metabolic syndrome: An intriguing association. Intern Emerg Med. 2011; Epub ahead of print.
10. Lam KB, Jordan RE, Jiang CQ, et al. Airflow obstruction and metabolic syndrome: The Guangzhou Biobank Cohort Study. Eur Respir J. 2010; 35: 317-23
11. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005; 25: 226-32
12. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009; 136: 1039-46
13. Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk. Curr Hypertens Rep. 2008; 10: 32-8
14. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56: 1113-32
15. Leone N, Ducimetiere P, Gariepy J, et al. Distension of the carotid artery and risk of coronary events: The Three-City study. Arterioscler Thromb Vasc Biol. 2008; 28: 1392-7
16. Osaka D, Shibata Y, Abe S, et al. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: The Takahata study. Intern Med. 2010; 49: 1489-99
17. Aida Y, Shibata Y, Osaka D, et al. The relationship between serum uric acid and spirometric values in participants in a health check: The Takahata study. Int J Med Sci. 2011; 8: 470-8
18. 16 in Japanese participants of the community-based annual health check: The Takahata study. Intern Med. 2011; 50: 87-93
19. Nemoto T, Shibata Y, Osaka D, et al. Impact of cigarette smoking on maximal expiratory flows in a general population: The Takahata study. Intern Med. 2011; 50: 2547-55
20. Shibata Y, Watanabe T, Osaka D, et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: The Takahata study. Int J Med Sci. 2011; 8: 514-22
21. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: The Hisayama study. Am J Kidney Dis. 2006; 48: 383-91
22. The Committee of Pulmonary Physiology JRS. Guidelines for pulmonary function tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo, 2004
23. Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007; 85: 35-9
24. Expert Panel on Detection E and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285: 2486-97
25. Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA. 2002; 287: 356-9
26. Nishiyama S, Watanabe T, Arimoto T, et al. Trends in coronary risk factors among patients with acute myocardial infarction over the last decade: The Yamagata AMI Registry. J Atheroscler Thromb. 2010; 17: 989-98
27. Park BH, Park MS, Chang J, et al. Chronic obstructive pulmonary disease and metabolic syndrome: A nationwide survey in Korea. Int J Tuberc Lung Dis. 2012; 16: 694-700
28. Devaraj S, Jialal I. Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res. 2012; 2012: 585018
29. Arao T, Takabatake N, Sata M, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med. 2003; 44: 1747-54
30. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001; 163: 737-44
31. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000; 106: 1311-9
32. Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 178: 1211-8
33. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J. 2008; 72: 415-9
34. Thompson AM, Zhang Y, Tong W, et al. Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from inner mongolia, china. BMC Endocr Disord. 2011; 11: 16
35. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of c-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis Thrombosis and Vascular Biology. 1997; 17: 2167-76
36. Nakajima K, Kubouchi Y, Muneyuki T, et al. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008; 134: 712-8
37. Yeh F, Dixon AE, Marion S, et al. Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: The Strong Heart Study. Diabetes Care. 2011; 34: 2306-13.